SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-04-064318
Filing Date
2004-04-19
Accepted
2004-04-19 10:44:18
Documents
5
Period of Report
2004-05-21
Effectiveness Date
2004-04-19

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 629191
3 GRAPHIC g77343g68b73.jpg GRAPHIC 11132
4 GRAPHIC g77343g88d11.jpg GRAPHIC 14308
5 GRAPHIC g77343g94c27.jpg GRAPHIC 93340
6 GRAPHIC g77343g97z57.jpg GRAPHIC 9768
  Complete submission text file 0001193125-04-064318.txt   759620
Mailing Address
Business Address 201 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12465 | Film No.: 04739656
SIC: 2834 Pharmaceutical Preparations